NEW YORK (GenomeWeb) – GenMark Diagnostics yesterday reported that it expects a 28 percent rise in its first quarter revenues to $10.1 million amid the placement of 22 of its XT-8 analyzers during the period. The total installed base of analyzers in the US is now 562.

The firm reiterated its full-year 2015 revenue guidance of between $38 million and $40 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.